325 related articles for article (PubMed ID: 15124502)
1. Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data.
Rolnick SJ; Hart G; Barton MB; Herrinton L; Flores SK; Paulsen KJ; Husson G; Harris EL; Geiger AM; Elmore JG; Fletcher SW
Am J Manag Care; 2004 Apr; 10(4):257-62. PubMed ID: 15124502
[TBL] [Abstract][Full Text] [Related]
2. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
[TBL] [Abstract][Full Text] [Related]
3. A high positive predictive value algorithm using hospital administrative data identified incident cancer cases.
Baldi I; Vicari P; Di Cuonzo D; Zanetti R; Pagano E; Rosato R; Sacerdote C; Segnan N; Merletti F; Ciccone G
J Clin Epidemiol; 2008 Apr; 61(4):373-9. PubMed ID: 18313562
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer incidence using administrative data: correction with sensitivity and specificity.
Couris CM; Polazzi S; Olive F; Remontet L; Bossard N; Gomez F; Schott AM; Mitton N; Colonna M; Trombert B
J Clin Epidemiol; 2009 Jun; 62(6):660-6. PubMed ID: 19070463
[TBL] [Abstract][Full Text] [Related]
5. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
6. [Performance evaluation of hospital claims database for the identification of incident central nervous system tumors compared with a cancer registry in Gironde, France, 2004].
Coureau G; Baldi I; Savès M; Jaffré A; Barat C; Gruber A; Loiseau H; Kostrzewa A; Servas V; Salamon R; Gilleron V
Rev Epidemiol Sante Publique; 2012 Aug; 60(4):295-304. PubMed ID: 22704681
[TBL] [Abstract][Full Text] [Related]
7. Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006.
De Roos AJ; Deeg HJ; Onstad L; Kopecky KJ; Bowles EJ; Yong M; Fryzek J; Davis S
Am J Hematol; 2010 Oct; 85(10):765-70. PubMed ID: 20815079
[TBL] [Abstract][Full Text] [Related]
8. The impact of a change in Medicare reimbursement policy and HEDIS measures on stage at diagnosis among Medicare HMO and fee-for-service female breast cancer patients.
Habermann EB; Virnig BA; Riley GF; Baxter NN
Med Care; 2007 Aug; 45(8):761-6. PubMed ID: 17667310
[TBL] [Abstract][Full Text] [Related]
9. Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods.
O'Connor PJ; Rush WA; Pronk NP; Cherney LM
Am J Manag Care; 1998 Mar; 4(3):335-42. PubMed ID: 10178496
[TBL] [Abstract][Full Text] [Related]
10. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
11. The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer.
Kirsner RS; Ma F; Fleming L; Federman DG; Trapido E; Duncan R; Wilkinson JD
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):769-73. PubMed ID: 16614122
[TBL] [Abstract][Full Text] [Related]
12. The sensitivity of Medicare data for identifying incident cases of invasive melanoma (United States).
Barzilai DA; Koroukian SM; Neuhauser D; Cooper KD; Rimm AA; Cooper GS
Cancer Causes Control; 2004 Mar; 15(2):179-84. PubMed ID: 15017130
[TBL] [Abstract][Full Text] [Related]
13. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review.
Field RW; Smith BJ; Platz CE; Robinson RA; Neuberger JS; Brus CP; Lynch CF
J Natl Cancer Inst; 2004 Jul; 96(14):1105-7. PubMed ID: 15265973
[TBL] [Abstract][Full Text] [Related]
16. Kentucky breast cancer report card.
Friedell GH; Linville LH; Sorrell CL; Huang B
J Ky Med Assoc; 2003 Oct; 101(10):449-54. PubMed ID: 14593789
[TBL] [Abstract][Full Text] [Related]
17. Identification of hospital-acquired catheter-associated urinary tract infections from Medicare claims: sensitivity and positive predictive value.
Zhan C; Elixhauser A; Richards CL; Wang Y; Baine WB; Pineau M; Verzier N; Kliman R; Hunt D
Med Care; 2009 Mar; 47(3):364-9. PubMed ID: 19194330
[TBL] [Abstract][Full Text] [Related]
18. Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.
Kim HM; Goodman M; Kim BI; Ward KC
J Registry Manag; 2011; 38(3):120-31. PubMed ID: 22223054
[TBL] [Abstract][Full Text] [Related]
19. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2005 Mar; 90(2):127-37. PubMed ID: 15803359
[TBL] [Abstract][Full Text] [Related]
20. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
